Effects of interferon- and interleukin-2 on the expressions of matrix metalloproteinases and their inhibitors in human renal cell carcinoma cells

Author： Kim S. Lee J. Lee I. Shin K. Park H. Lee T. Woo Y. Jang S.

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.2, Iss.1, 2003-02, pp. : 182-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of adenovirus to human renal cell carcinoma cells

By Jongmans W. van den Oudenalder K. Tiemessen D.M. Molkenboer J. Willemsen R. Mulders P.F.A. Oosterwijk E.

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 559-565

Elsevier

Access to resources Recommend Favorite

Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment

By Taneja S.S. Pierce W. Figlin R. Belldegrun A.

Urology, Vol. 45, Iss. 6, 1995-06 ,pp. : 911-924

Elsevier

Access to resources Recommend Favorite

Serum Levels of Soluble Interleukin-2 Receptor in Renal Cell Carcinoma

By Matsumoto T. Furukawa A. Sumiyoshi Y. Akiyama K.-y. Kanayama H.-o. Kagawa S.

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 145-149

Elsevier

Access to resources Recommend Favorite

Immunohistochemical localization of nephrocalcin, a kidney-specific glycoprotein, to renal cell carcinoma - biosynthesis by human renal carcinoma cells in vitro and in vivo

By Michaels E.K. Ghosh L. Nakagawa Y. Netzer M.F. Vidal P. Arsenault D. Ito H.

Urology, Vol. 52, Iss. 5, 1998-11 ,pp. : 920-924

Elsevier

Access to resources Recommend Favorite

Pretreatment with Interleukin-2 Modulates Peri-Operative Immuno-Dysfunction in Patients with Renal Cell Carcinoma

By Bohm M. Ittenson A. Schierbaum K.F. Rohl F.-W. Ansorge S. Allhoff E.P.

European Urology, Vol. 41, Iss. 4, 2002-04 ,pp. : 458-468

Elsevier

Access to resources Recommend Favorite